Pheochromocytoma and primary aldosteronism: Diagnostic approaches

Endocrinology and Metabolism Clinics of North America

Volumn 26, Issue 4, 1997, Pages 801-827

  Young W F , Jr ^a  

^a MAYO CLINIC   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADRENALIN; CREATININE; METADRENALIN; NORADRENALIN; VANILMANDELIC ACID;

ADRENAL SCINTISCANNING; CATECHOLAMINE RELEASE; CLINICAL FEATURE; DIAGNOSTIC APPROACH ROUTE; GENE MUTATION; HORMONE DETERMINATION; HUMAN; HYPERTENSION; PATHOGENESIS; PHEOCHROMOCYTOMA; PRIMARY HYPERALDOSTERONISM; PRIORITY JOURNAL; REVIEW; SWEATING; TREATMENT PLANNING; TUMOR LOCALIZATION; TUMOR SUPPRESSOR GENE;

EID: 0030669145     PISSN: 08898529     EISSN: None     Source Type: Journal    
DOI: 10.1016/s0889-8529(05)70283-8     Document Type: Review

References (84)

1. N.O. Atuk T. McDonald T. Wood Familial pheochromocytoma, hypercalcemia, and von Hippel-Lindau disease: A ten-year study of a large family Medicine 58 1979 209
2. W.A. Banks A.J. Kastin E.G. Biglieri Primary adrenal hyperplasia: A new subset of primary hyperaldosteronism J Clin Endocrinol Metab 58 1984 783
3. G. Berglund O. Andersson L. Wilhelmsen Prevalence of primary and secondary hypertension: Studies in a random population sample BMJ 2 1976 554
4. J.D. Blumenfeld J.E. Sealey Y. Schlussel Diagnosis and treatment of primary aldosteronism Ann Intern Med 121 1994 877
5. H. Brauch T. Kishida D. Glavac von Hippel-Lindau (VHL) disease with pheochromocytoma in the Black Forest region of Germany: Evidence for a founder effect Hum Genet 95 1995 551
6. E.L. Bravo F.M. Fouad-Tarazi R.C. Tarazi Clinical implications of primary aldosteronism with resistent hypertension Hypertension 11 suppl 1 1988 1207
7. E.L. Bravo R.C. Tarazi H.P. Dustan The changing clinical spectrum of primary aldosteronism Am J Med 74 1983 641
8. M.P. Canale E.L. Bravo Diagnostic specificity of serum chromogranin-A for pheochromocytoma in patients with renal dysfunction J Clin Endocrinol Metab 78 1994 1139
9. J.A. Carney The triad of gastric epithelioid leiomyosarcoma, pulmonary chondroma, and functioning extra-adrenal paraganglioma: A five-year review Medicine 62 1983 159
10. O. Celen M.J. O'Brien J.C. Melby Factors influencing outcome of surgery for primary aldosteronism Arch Surg 131 1996 646
11. D. Chauveau F. Martinez S. Houhou Malignant hypertension secondary to pheochromocytoma in a hemodialyzed patient Am J Kidney Dis 21 1993 52
12. J.W. Conn Presidential address: Part I. Painting background. Part II. Primary aldosteronism, a new clinical syndrome J Lab Clin Med 45 1955 3
13. J.W. Conn W.H. Beierwaltes L.M. Lieberman Primary aldosteronism: Preoperative tumor visualization by scintillation scanning J Clin Endocrinol Metab 33 1971 713
14. C. Cope L. Delbridge J. Philips Prognostic significance of nuclear DNA content in phaeochromocytoma Aust NZ J Surg 61 1991 695
15. J.L. Doppman J.R. Gill Jr Hyperaldosteronism: Sampling the adrenal veins Radiology 198 1996 309
16. J.L. Doppman J.R. Gill Jr D.L. Miller Distinction between hyperaldosteronism due to bilateral hyperplasia and unilateral aldosteronoma: Reliability of CT Radiology 184 1992 677
17. R.G. Dluhy G.H. Williams Glucocorticoid-remediable aldosteronism Cardiovasc Res 31 1996 870
18. C. Eng D. Clayton I. Schuffenecker The relationship between specific RET proto-oncogene mutations and disease phenotype in multiple endocrine neoplasia type 2: International RET mutation consortium analysis JAMA 276 1996 1575
19. L. Fernandez-Cruz P. Taura A. Saenz Laparoscopic approach to pheochromocytoma: Hemodynamic changes and catecholamine secretion World J Surg 20 1996 762
20. L.M. Fishman O. Kuchel G.W. Liddle Incidence of primary aldosteronism uncomplicated “essential” hypertension: A prospective study with elevated aldosterone secretion and suppressed plasma renin activity used as diagnostic criteria JAMA 205 1968 497
21. A. Ganguly A.J. Dowdy J.A. Luetscher Anomalous postural response of plasma aldosterone concentration in patient with aldosterone-producing adrenal adenoma J Clin Endocrinol Metab 36 1973 401
22. A. Ganguly G.L. Robertson Elevated threshold for vasopressin release in primary aldosteronism [abstract] Clin Res 28 1980 330A
23. R.D. Gordon S.M. Hamlet T.J. Tunny Aldosterone-producing adenomas responsive to angiotensin pose problems in diagnosis Clin Exp Pharmacol Physiol 14 1987 175
24. R.D. Gordon M. Stowasser T.J. Tunny High incidence of primary aldosteronism in 199 patients referred with hypertension Clin Exp Pharmacol Physiol 21 1994 315
25. R.W. Grady W.M. Kaylor J.-C. Lee Renal pathology in patients with primary hyperaldosteronism secondary to an adrenal cortical adenoma Urology 48 1996 369
26. D.J. Gross N. Avishai V. Meiner Familial pheochromocytoma associated with a novel mutation in the von Hippel-Lindau gene J Clin Endocrinol Metab 81 1996 147
27. E. Heron G. Chatellier E. Billaud The urinary metanephrine-to-creatinine ratio for the diagnosis of pheochromocytoma Ann Intern Med 125 1996 300
28. K. Hiramatsu T. Yamada Y. Yukimura A screening test to identify aldosterone-producing adenoma by measuring plasma renin activity: Results in hypertension patients Arch Intern Med 141 1981 1589
29. M.J. Hogan J. McRae M. Schambelan Location of aldosterone-producing adenomas with I-19-iodocholesterol N Engl J Med 294 1976 410
30. R.J. Hsiao R.J. Parmer M.A. Takiyyuddin Chromogranin A storage and secretion: Sensitivity and specificity for the diagnosis of pheochromocytoma Medicine 70 1991 33
31. I. Irony C.E. Kater E.G. Biglieri Correctable subsets of primary aldosteronism: Primary adrenal hyperplasia and renin responsive adenoma Am J Hypertension 3 1990 576
32. Y. Ito Y. Fujimoto T. Obara The role of epinephrine, norepinephrine, and dopamine in blood pressure disturbances in patients with pheochromocytomas World J Surg 16 1992 759
33. J.A. Jackson M. Kleerekoper D. Mendlovic Endocrine grand rounds: A 51-year-old man with accelerated hypertension, hypercalcemia, and right adrenal and paratracheal masses Endocrinologist 3 1993 5
34. A. Jose N.M. Kaplan Plasma renin activity in the diagnosis of primary aldosteronism: Failure to distinguish primary aldosteronism from essential hypertension Arch Intern Med 123 1969 141
35. V. Kalff B. Shapiro R. Lloyd The spectrum of pheochromocytoma in hypertensive patients with neurofibromatosis Arch Intern Med 142 1982 2092
36. Kudva YC, Young WF Jr: Sensitivity of 24-hour urine metanephrines and fractionated catecholamines in benign sporadic adrenal pheochromocytoma [abstract OR28-5]. In Programs and Abstracts of the 79th Annual Meeting of The Endocrine Society, Minneapolis, 1997, p 106
37. S.W.J. Lamberts W.H. Bakker J.C. Reubi Somatostatin-receptor imaging in the localization of endocrine tumors N Engl J Med 323 1990 1246
38. G.A. Ledger S. Khosla N.M. Lindor Genetic testing in the diagnosis and management of multiple endocrine neoplasia type II Ann Intern Med 122 1995 118
39. J.W.M. Lenders H.R. Deiser D.S. Goldstein Plasma metanephrines in the diagnosis of pheochromocytoma Ann Intern Med 123 1995 101
40. R.P. Lifton R.G. Dluhy M. Powers A chimeric 11β-hydroxylase/aldosterone synthase gene causes glucocorticoid-remediable aldosteronism and human hypertension Nature 355 1992 262
41. I.J. Mader L.T. Iseri Spontaneous hypopotassemia, hypomagnesemia, alkalosis and tetany due to hypersecretion of corticosterone-like mineralocorticoid Am J Med 19 1955 976
42. W.M. Manger R.W. Gifford Jr Diagnosis Clinical and Experimental Pheochromocytoma 1996 Blackwell Science Cambridge, MA
43. C.H. Mayo Paroxysmal hypertension with tumor of retroperitoneal nerve JAMA 89 1927 1047
44. T.J. McKenna S.J. Sequeira A. Heffernan Diagnosis under random conditions of all disorders of the renin-angiotensin-aldosterone axis, including primary hyperaldosteronism J Clin Endocrinol Metab 73 1991 952
45. J.C. Melby R.F. Spark S.L. Dale Diagnosis and localization of aldosterone-producing adenomas by adrenal-vein catheterization N Engl J Med 277 1967 1050
46. J.C. Melby S.T. Azar Adrenal steroids and hypertension: New aspects Endocrinologist 3 1993 344
47. J.M. Miles H.W. Wahner P.C. Carpenter Adrenal scintiscanning with NP-59, a new radioiodinated cholesterol agent Mayo Clin Proc 54 1979 321
48. T. Mouri M. Sone K. Takahashi Neuropeptide Y as a plasma marker for phaeochromocytoma, ganglioneuroblastoma, and neuroblastoma Clin Sci 83 1992 205
49. T. Nakada H. Koike T. Katayama Evidence for a defect in urinary concentrating ability in primary aldosteronism and its reversal by adrenal surgery Urol Int 42 1987 295
50. O. Nativ C.S. Grant S.G. Sheps The clinical significance of nuclear DNA ploidy pattern in 184 patients with pheochromocytoma Cancer 69 1992 2683
51. R.C. Newbould G.A. Ross J.E. Dacie The use of venous catheterization in the diagnosis and localization of bilateral phaeochromocytomas Clin Endocrinol 35 1991 55
52. K. Nomura K. Kusakabe M. Maki Iodomethylnorcholesterol uptake in an aldosteronoma shown by dexamethasone-suppression scintigraphy: Relationship to adenoma size and functional activity J Clin Endcrinol Metab 71 1990 825
53. D.S. O'Riordain W.F. Young Jr C.S. Grant Clinical spectrum and outcome of functional extraadrenal paraganglioma World J Surg 20 1996 916
54. D.R. Radin C. Manoogian J.L. Nadler 1992. Diagnosis of primary hyperaldosteronism: Importance of correlating CT findings with endocrinologic studies Am J Rad 158 1992 553
55. G.M. Rich S. Ulick S. Cook Glucocorticoid-remediable aldosteronism in a large kindred: Clinical spectrum and diagnosis using a characteristic biochemical phenotype Ann Intern Med 116 1992 813
56. F. Saegesser Cesar Roux (1857-1934) et son epoque [Cesar Roux (1857-1934) and his times] Rev Med Suisse Romande 104 1984 403
57. B. Shapiro M.D. Gross L. Fig Localization of functioning sympathoadrenal lesions E.G. Biglieri J.C. Melby Endocrine Hypertension 1990 Raven Press New York 235
58. R. Sheaves J. Goldin R.H. Reznek Relative value of computed tomography scanning and venous sampling in establishing the cause of primary hyperaldosteronism Eur J Endocrinol 134 1996 308
59. S.G. Sheps N.-S. Jiang G.G. Klee Diagnostic evaluation of pheochromocytoma Endocrinol Metab Clin North Am 17 1988 397
60. B.L. Shulkin D.M. Wieland M. Schwaiger PET scanning with hydroxyephedrine: An approach to the localization of pheochromocytoma J Nucl Med 33 1992 1125
61. J.A. Sigurdsson C. Bengtsson E. Tibblin Prevalence of secondary hypertension in a population sample of Swedish women Eur Heart J 4 1983 424
62. M.H. Silber Restless leg syndrome Mayo Clin Proc 72 1997 261
63. G. Stenstrom K. Svardsudd Phaechromocytoma in Sweden, 1958–81: An analysis of the National Cancer Registry Data Acta Med Scand 220 suppl 1986 225
64. M. Stowasser R.D. Gordon T.J. Tunny Familial hyperaldosteronism type II: Five families with a new variety of primary aldosteronism Clin Exp Pharmacol Physiol 19 1992 319
65. D.H.P. Streeten N. Tomycz G.H. Anderson Jr Reliability of screening methods for the diagnosis of primary aldosteronism Am J Med 67 1979 403
66. M. Stridsberg E.S. Husebye Chromogranin A and chromogranin B are sensitive circulating markers for phaeochromocytoma Eur J Endocrinol 136 1997 67
67. M. Stumvoll M. Radjaipour F. Seif Diagnostic considerations in pheochromocytoma and chronic hemodialysis: Case report and review of the literature Am J Nephrol 15 1995 147
68. F. Tenenbaum J. Lumbroso M. Schlumberger Comparison of radiolabeled octreotide and meta-iodobenzylguanidine (MIBG) scintigraphy in malignant pheochromocytoma J Nucl Med 36 1995 1
69. Thompson GB, Grant CS, van Heerden JA, et al: Laparoscopic versus open posterior adrenalectomy: A case-control study of 100 patients. Surgery, in press
70. T.J. Tunny R.D. Gordon S.A. Klemm Histological and biochemical distinctiveness of atypical aldosterone-producing adenomas responsive to upright posture and angiotensin Clin Endocrinol 34 1991 363
71. A.P.G. van Gils T.H.M. Falke A.R. van Erkel MR imaging and MIBG scintigraphy of pheochromocytomas and extraadrenal functioning paragangliomas Radiography 11 1991 37
72. J.A. van Heerden C.F. Roland J.A. Carney Long-term evaluation following resection of apparently benign pheochromocytoma(s)/paraganglioma(s) World J Surg 14 1990 325
73. B.R. Walker C.R.W. Edwards Dexamethasone-suppressible hypertension Endocrinologist 3 1993 87
74. I.A. Walker Selective venous catheterization and plasma catecholamine analysis in the diagnosis of phaeochromocytoma J R Soc Med 89 1996 216P
75. M.H. Weinberger N.S. Fineberg The diagnosis of primary aldosteronism and separation of two major subtypes Arch Intern Med 153 1993 2125
76. M.H. Weinberger C.E. Grim J.W. Hollifield Primary aldosteronism: Diagnosis, localization, and treatment Ann Intern Med 90 1979 386
77. R.K. Whalen A.F. Althausen G.H. Daniels Extra-adrenal pheochromocytoma J Urol 147 1992 1
78. W.F. Young Jr Pheochromocytoma: 1926 to 1993 Trends Endocrinol Metab 4 1993 122
79. W.F. Young Jr Phaeochromocytoma: How to catch a moonbeam in your hand Eur J Endocrinol 136 1997 28
80. W.F. Young Jr Primary aldosteronism: Update on diagnosis and treatment The Endocrinologist 7 1997 213
81. W.F. Young Jr M.J. Hogan Renin-independent hypermineralocorticoidism Trends Endocrinol Metab 5 1994 97
82. W.F. Young Jr G.G. Klee Primary aldosteronism: Diagnostic evaluation Endocrinol Metab Clin North Am 17 1988 367
83. W.F. Young Jr D.E. Maddox Spells: In search of a cause Mayo Clin Proc 70 1995 757
84. W.F. Young Jr A.W. Stanson C.S. Grant Primary aldosteronism: Adrenal venous sampling Surgery 120 1996 913